Literature DB >> 28499894

Pathophysiology of bone metastases from solid malignancies.

Philippe Clézardin1.   

Abstract

Bone metastases are common complications of many cancers. Among the mechanisms that set the scene for the development of bone metastases, several are shared by all forms of metastatic dissemination (pre-metastatic niche formation and chemotactic attraction of malignant cells, which invade the host tissue) and others are specific of bone tissue (homing of malignant cells to bone marrow niches and acquisition of an osteomimetic cell phenotype). After a latency period that can last several years, the malignant cells can proliferate into tumors that alter the normal bone remodeling process by inducing dysregulation of osteoblast and osteoclast function. These metastases may be lytic, characterized by major bone destruction; sclerotic, with excess bone formation; or mixed. Osteolysis occurs when the tumor cells stimulate osteoclast activity and inhibit osteoblast activity, whereas the opposite effects lead to bone sclerosis. Moreover, the mineralized bone matrix plays a major role in the formation of bone metastases, as its degradation releases growth factors and calcium that exert mitogenic effects on tumor cells. Thus, bone metastases are the site of a vicious circle in which mechanisms involved in bone resorption/formation promote tumor growth and vice versa.
Copyright © 2017. Published by Elsevier SAS.

Entities:  

Keywords:  Cancer; Metastasis; Metastatic niche; Micro-RNA; Osteoblast; Osteoclast

Mesh:

Substances:

Year:  2017        PMID: 28499894     DOI: 10.1016/j.jbspin.2017.05.006

Source DB:  PubMed          Journal:  Joint Bone Spine        ISSN: 1297-319X            Impact factor:   4.929


  11 in total

1.  Sema4D expression and secretion are increased by HIF-1α and inhibit osteogenesis in bone metastases of lung cancer.

Authors:  Wu-Gui Chen; Jing Sun; Wei-Wei Shen; Si-Zhen Yang; Ying Zhang; Xu Hu; Hao Qiu; Shang-Cheng Xu; Tong-Wei Chu
Journal:  Clin Exp Metastasis       Date:  2019-01-07       Impact factor: 5.150

2.  Machine learning for differentiating metastatic and completely responded sclerotic bone lesion in prostate cancer: a retrospective radiomics study.

Authors:  Emine Acar; Asım Leblebici; Berat Ender Ellidokuz; Yasemin Başbınar; Gamze Çapa Kaya
Journal:  Br J Radiol       Date:  2019-07-10       Impact factor: 3.039

3.  Hematopoietic or Osteoclast-Specific Deletion of Syk Leads to Increased Bone Mass in Experimental Mice.

Authors:  Dániel Csete; Edina Simon; Ahmad Alatshan; Petra Aradi; Csaba Dobó-Nagy; Zoltán Jakus; Szilvia Benkő; Dávid S Győri; Attila Mócsai
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

Review 4.  Influence of the TGF-β Superfamily on Osteoclasts/Osteoblasts Balance in Physiological and Pathological Bone Conditions.

Authors:  Jessica Jann; Suzanne Gascon; Sophie Roux; Nathalie Faucheux
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

5.  Evaluation of Response to Immune Checkpoint Inhibitors Using a Radiomics, Lesion-Level Approach.

Authors:  Chorog Song; Hyunjin Park; Ho Yun Lee; Seunghak Lee; Joong Hyun Ahn; Se-Hoon Lee
Journal:  Cancers (Basel)       Date:  2021-12-01       Impact factor: 6.639

6.  Transcriptomic Response to Acidosis Reveals Its Contribution to Bone Metastasis in Breast Cancer Cells.

Authors:  Ana Sayuri Yamagata; Paula Paccielli Freire; Nícolas Jones Villarinho; Ramon Handerson Gomes Teles; Kelliton José Mendonça Francisco; Ruy Gastaldoni Jaeger; Vanessa Morais Freitas
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

7.  Proteomic Comparison of Bone Marrow Derived Osteoblasts and Mesenchymal Stem Cells.

Authors:  Elise Aasebø; Annette K Brenner; Maria Hernandez-Valladares; Even Birkeland; Frode S Berven; Frode Selheim; Øystein Bruserud
Journal:  Int J Mol Sci       Date:  2021-05-26       Impact factor: 5.923

8.  Development of clinically relevant in vivo metastasis models using human bone discs and breast cancer patient-derived xenografts.

Authors:  Diane Lefley; Faith Howard; Fawaz Arshad; Steven Bradbury; Hannah Brown; Claudia Tulotta; Rachel Eyre; Denis Alférez; J Mark Wilkinson; Ingunn Holen; Robert B Clarke; Penelope Ottewell
Journal:  Breast Cancer Res       Date:  2019-11-29       Impact factor: 6.466

9.  MicroRNAs Possibly Involved in the Development of Bone Metastasis in Clear-Cell Renal Cell Carcinoma.

Authors:  Lisa Kinget; Eduard Roussel; Diether Lambrechts; Bram Boeckx; Loïc Vanginderhuysen; Maarten Albersen; Cristina Rodríguez-Antona; Osvaldo Graña-Castro; Lucía Inglada-Pérez; Annelies Verbiest; Jessica Zucman-Rossi; Gabrielle Couchy; Stefano Caruso; Annouschka Laenen; Marcella Baldewijns; Benoit Beuselinck
Journal:  Cancers (Basel)       Date:  2021-03-28       Impact factor: 6.639

Review 10.  Contemporary Insights into Cancer Cachexia for Oncology Nurses.

Authors:  Deborah A Boyle
Journal:  Asia Pac J Oncol Nurs       Date:  2021-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.